Follow
Ye-Mao Liu
Ye-Mao Liu
Institute of Model Animal, Wuhan University
Verified email at whu.edu.cn
Title
Cited by
Cited by
Year
Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with …
P Zhang, L Zhu, J Cai, F Lei, JJ Qin, J Xie, YM Liu, YC Zhao, X Huang, ...
Circulation research 126 (12), 1671-1681, 2020
12922020
Longitudinal association between markers of liver injury and mortality in COVID‐19 in China
F Lei, YM Liu, F Zhou, JJ Qin, P Zhang, L Zhu, XJ Zhang, J Cai, L Lin, ...
Hepatology 72 (2), 389-398, 2020
4552020
Redefining cardiac biomarkers in predicting mortality of inpatients with COVID-19
JJ Qin, XU Cheng, F Zhou, F Lei, G Akolkar, J Cai, XJ Zhang, A Blet, J Xie, ...
Hypertension 76 (4), 1104-1112, 2020
1672020
Metformin is associated with higher incidence of acidosis, but not mortality, in individuals with COVID-19 and pre-existing type 2 diabetes
X Cheng, YM Liu, H Li, X Zhang, F Lei, JJ Qin, Z Chen, KQ Deng, L Lin, ...
Cell metabolism 32 (4), 537-547. e3, 2020
1522020
The neutrophil-to-lymphocyte ratio determines clinical efficacy of corticosteroid therapy in patients with COVID-19
J Cai, H Li, C Zhang, Z Chen, H Liu, F Lei, JJ Qin, YM Liu, F Zhou, X Song, ...
Cell metabolism 33 (2), 258-269. e3, 2021
1122021
Kidney function indicators predict adverse outcomes of COVID-19
YM Liu, J Xie, MM Chen, X Zhang, X Cheng, H Li, F Zhou, JJ Qin, F Lei, ...
Med 2 (1), 38-48. e2, 2021
772021
Comparative impacts of ACE (angiotensin-converting enzyme) inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality
F Zhou, YM Liu, J Xie, H Li, F Lei, H Yang, JJ Qin, J Cai, XJ Zhang, B Wu, ...
Hypertension 76 (2), e15-e17, 2020
722020
Functional analysis of OsPGIP1 in rice sheath blight resistance
R Wang, L Lu, X Pan, Z Hu, F Ling, Y Yan, Y Liu, Y Lin
Plant molecular biology 87, 181-191, 2015
652015
Activating or inhibiting Nrf2?
XY Chu, YM Liu, HY Zhang
Trends in Pharmacological Sciences 38 (11), 953-955, 2017
192017
Phosphates as energy sources to expand metabolic networks
T Tian, XY Chu, Y Yang, X Zhang, YM Liu, J Gao, BG Ma, HY Zhang
Life 9 (2), 43, 2019
182019
A bidirectional relationship between hyperuricemia and metabolic dysfunction-associated fatty liver disease
C Yang, Q He, Z Chen, JJ Qin, F Lei, YM Liu, W Liu, MM Chen, T Sun, ...
Frontiers in Endocrinology 13, 821689, 2022
172022
Facilitating anti-cancer combinatorial drug discovery by targeting epistatic disease genes
Y Quan, MY Liu, YM Liu, LD Zhu, YS Wu, ZH Luo, XZ Zhang, SZ Xu, ...
Molecules 23 (4), 736, 2018
152018
A risk score based on baseline risk factors for predicting mortality in COVID-19 patients
Z Chen, J Chen, J Zhou, F Lei, F Zhou, JJ Qin, XJ Zhang, L Zhu, YM Liu, ...
Current Medical Research and Opinion 37 (6), 917-927, 2021
132021
Systems chemical genetics-based drug discovery: prioritizing agents targeting multiple/reliable disease-associated genes as drug candidates
Y Quan, ZH Luo, QY Yang, J Li, Q Zhu, YM Liu, BM Lv, ZJ Cui, X Qin, ...
Frontiers in Genetics 10, 474, 2019
122019
Systems genetic validation of the SNP-metabolite association in rice via metabolite-pathway-based phenome-wide association scans
Y Lu, Y Liu, X Niu, Q Yang, J Xia
Frontiers in plant science 6, 165658, 2015
92015
HPO-Shuffle: an associated gene prioritization strategy and its application in drug repurposing for the treatment of canine epilepsy
S Wang, X Meng, Y Wang, Y Liu, J Xia
Bioscience Reports 39 (9), BSR20191247, 2019
72019
Exploring the pathogenesis of canine epilepsy using a systems genetics method and implications for anti-epilepsy drug discovery
ZJ Cui, YM Liu, Q Zhu, J Xia, HY Zhang
Oncotarget 9 (17), 13181, 2018
32018
A corpus-oriented perspective on terminologies of side effect and adverse reaction in support of text retrieval for drug repurposing
AC Fang, Y Liu, Y Lu, J Cao, J Xia
International Journal of Data Mining and Bioinformatics 21 (3), 269-286, 2018
32018
Gastrodin inhibits prostate cancer proliferation by targeting canonical Wnt/β-catenin signaling pathway
YM Liu, AD Wu, Y Chen, TF Ma, BZ Dong, ZG She, ML Yi, WM Mao
Medical Oncology 41 (1), 1-10, 2024
2024
The neutrophil-to-lymphocyte ratio determines clinical efficacy of corticosteroids therapy in patients with COVID-19 (preprint)
J Cai, H Li, YM Liu, C Zhang, F Lei, JJ Qin, F Zhou, X Song, L Bai, J Zhou, ...
2020
The system can't perform the operation now. Try again later.
Articles 1–20